Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jing-Zhou Chen

Jing-Zhou Chen is recorded as CEO and CFO at Vitaspring Biomedical Co. Ltd. (VSBC). Vitaspring Biomedical Co. Ltd. reported in an 8-K filed September 10, 2026 that Jing-Zhou Chen was appointed President, effective September 7, 2026. Vitaspring Biomedical Co. Ltd. reported in an 8-K filed September 10, 2026 that Jing-Zhou Chen was appointed Chief Financial Officer, effective September 7, 2026. Vitaspring Biomedical Co. Ltd. reported in an 8-K filed September 10, 2026 that Jing-Zhou Chen was appointed Chief Executive Officer, effective September 7, 2026.

“Effective at 11:57 p.m. Pacific Time on September 7, 2026, Dr. Ssu-Chuan Lai, as the sole director then in office, appointed Jing-Zhou Chen as the Company's Chief Executive Officer, President, Chief Financial Officer, and Secretary, to serve at the pleasure of the Board and until his successor is duly appointed and qualified, or until his earlier death, resignation or removal.”
Vitaspring Biomedical Co. Ltd. Form 8-K, filed September 10, 2026 · Read the filing
“Effective at 11:57 p.m. Pacific Time on September 7, 2026, Dr. Ssu-Chuan Lai, as the sole director then in office, appointed Jing-Zhou Chen as the Company's Chief Executive Officer, President, Chief Financial Officer, and Secretary, to serve at the pleasure of the Board and until his successor is duly appointed and qualified, or until his earlier death, resignation or removal.”
Vitaspring Biomedical Co. Ltd. Form 8-K, filed September 10, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Vitaspring Biomedical Co. Ltd.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.